While not claiming complete success, US National Institute of Health researchers says the vaccines, administered in combination, produced good results, especially the one that was DNA-based. It was found to be "safe and well-tolerated," according to a news release from the Infectious Disease Society of America.
Two problems still exist, the scientists say. The DNA-based vaccine is less potent than other anti-Aids immunisations, and the other vaccine may be subject to some outside influence.
The findings are published online in the December 15 issue of The Journal of Infectious Diseases. – (HealthDayNews)
Read more:HIV/Aids Centre
November 2006